Increased scalp skin and serum 5α-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia

Archives of Dermatology

Volumn 133, Issue 9, 1997, Pages 1129-1133

  Boudou, Philippe ^a   Reygagne, Pascal ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; STEROID 5ALPHA REDUCTASE;

ADULT; ARTICLE; CASE REPORT; HAIR ANALYSIS; HAIR DISEASE; HAIR GROWTH; HISTOLOGY; HUMAN; HUMAN TISSUE; KINKY HAIR; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL; SCALP; SCANNING ELECTRON MICROSCOPY;

EID: 0030886325     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.9.1129     Document Type: Article

References (44)

1. Wise F, Sulzberger MB. Acquired progressive kinking of the scalp hair accompanied by changes in its pigmentation. Arch Dermatol Syphilol. 1932;25:99-110.
2. Grant PW. A case of wooly hair naevus. Arch Dis Child. 1960;35:512-514.
3. Knierer W. Allotrichia circumscripta symmetrica capillitii. Dermatol Wochenschrift. 1955;132:794.
4. Coupe RL, Johnston MM. Acquired progressive kinking of the hair. Arch Dermatol. 1969;100:191-195.
5. McCarty AG, Garrie SA, Skipworth GB. Acquired progressive kinking of the hair: a case report. Bull Soc Milit Dermatol. 1972;20:35-40.
6. Bovenmyer DA. Woolly hair naevus. Cutis. 1979;24:322-325.
7. Mortimer PS, Gummer C, English J, Dawber RPR. Acquired progressive kinking of the hair. Arch Dermatol. 1985;121:1031-1033.
8. Rebora A, Guarrera M. Acquired progressive kinking of the hair. J Am Acad Dermatol. 1985;12:933-936.
9. Balsa RE, Ingratta SM, Alvarez AG. Acquired kinking of the hair: a methodologic approach. J Am Acad Dermatol. 1986;15:1133-1136.
10. Cullen SI, Fulghum D. Acquired progressive kinking of the hair. Arch Dermatol. 1989;125:252-255.
11. English JSC, Mortimer PS. Acquired progressive kinking of the hair. Clin Exp Dermatol. 1984;9:102-104.
12. Pfahler. Epilation of half the scalp in a patient with straight hair, followed by regrowth of curly hair. Arch Dermatol. 1927;15:214.
13. Esterly NB, Lavin MP, Garancis JC. Acquired progressive kinking of the hair. Arch Dermatol. 1989;125:813-815.
14. Rebora A, Chiappara GM, Guarrera M, Parodi A. Cheveux crépus acquis: un cas féminin avec revue de la littérature. Ann Dermatol Venereol. 1990;117:29-31.
15. Graham RM, James MP, Ferguson DJP, Guerrier CW. Acquired kinking of the hair associated with etretinate therapy. Clin Exp Dermatol. 1985;10:426-431.
16. Bunker CB, Maurice PDL, Dowd PM. Isotretinoin and curly hair. Clin Exp Dermatol. 1990;15:143-145.
17. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186:1213-1215.
18. Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones, I: testosterone metabolism in isolated hairs. J Clin Endocrinol Metab. 1974;38:811-819.
19. Adachi K, Kano M. Zdenyl cyclase in human hair follicles: its inhibition by dihydrotestosterone. Biochem Biophys Res Commun. 1970;41:884-890.
20. Vermorken AJM, Sultan C. The pilosebaceous unit: hormonal regulation in relation to cellular differentiation. Clin Dermatol. 1988;6:52-66.
21. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acard Sci. 1951;53:708-728.
22. Orfanos CE. Andtogenetic Alopecia: Clinical Aspects and Treatment. New York, NY: Springer-Verlag NY Inc; 1990:485-527.
23. Boudou P, Chivot M, Vexiau P, et al. Evidence for decreased androgen 5α-reduction in skin and liver of men with severe acne after 13-cis retinoic acid treatment. J Clin Endocrinol Metab. 1994;78:1064-1069.
24. Hamilton JB. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat. 1942;71:451-480.
25. Mellin TN, Busch RD, Rasmusson GH. Azasteroids as inhibitors of testosterone 5 alpha-reductase in mammalian skin. J Steroid Biochem Mol Biol. 1993;44: 121-131.
26. Sawaya ME, Honig LS, Garland LD, Hsia SL. D5-3β-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male pattern baldness. J Invest Dermatol. 1988;91:101-105.
27. Sawaya ME. Steroid chemistry and hormone controls during the hair follicle cycle. Ann N Y Acad Sci. 1991;642:376-383.
28. Bingham KD, Shaw DA. The metabolism of testosterone by human male scalp skin. J Endocrinol. 1973;57:111-121.
29. Puerto AM, Mallol J. Regional scalp differences of the androgenic metabolic pattern in subjects affected by male pattern baldness. Rev Esp Fisiol. 1990;46:289-296.
30. Dallob AL, Sadick NS, Unger W, et al. The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab. 1994;79:703-706.
31. Pitts RL. Serum elevation of dehydroepiandrosterone-sulfate associated with male pattern baldness in young men. JAMA. 1987;16:571-573.
32. Schmidt JB, Lindmaier A, Spona J. Hormonal parameters in androgenetic hair loss in the male. Dermatologica. 1991;182:214-217.
33. Vermeulen A, Giagulli VA, De Schepper P, Buntix A, Stoner E. Hormonal effects of an orally active 4-azasteroid inhibitor of 5α-reductase in humans. Prostate. 1989;14:45-53.
34. Gormley GJ, Stoner E, Rittmaster RS, et al. Effects of finasteride (MK-906), a 5α-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab. 1990;70:1136-1141.
35. Harris G, Azzolina B, Baginsky W, et al. Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp. Proc Natl Acad Sci U S A. 1992;89:10 787-10 791.
36. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest. 1993;92:903-910.
37. Coupe RL. Acquired progressive kinking of the hair. Arch Dermatol. 1986;122:133.
38. Rhodes L, Harper J, Uno H, et al. The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides). J Clin Endocrinol Metab. 1994;79:991-996.
39. Kaufman KD. Clinical studies on the effects of oral finasteride, a type II 5α-reductase inhibitor, on scalp hair in men with male pattern baldness. In: Van Neste DJJ, Randall VA, eds. Hair Research for the Next Millenium. New York, NY: Elsevier Science Inc: 1996:363-365.
40. Eicheler W, Dreher M, Hoffman R, Happle R, Aumüller G. Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol. 1995;133:371-376.
41. McConnell JD, Wilson JD George FW Geller J, Pappas F, Stoner E. Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab. 1992;74:505-508.
42. Norman RW, Coakes KE, Wright AS, Rittmaster RS. Androgen metabolism in men receiving finasteride before prostatectomy. J Urol. 1993;150:1736-1739.
43. Courchay G, Boyera N, Bernard BA, Mahe Y. Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacol. 1996;9:169-176.
44. Tian G, Stuart JD, Moss ML, et al. 17α-(n-tert-butylcarbamoyl)-4-aza-5α-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5α-reductase 1. Biochemistry. 1994;44:2291-2296.